ANALYSIS: Investors have lost millions and companies have collapsed, but medicinal cannabis players still see a bright future.
Trilogy International's share price has been on fire over the past couple of years, with the company confidently captivating the Australasian market.
Shoeshine was astonished to discover that Wellington Drive Technologies did something in late August that it's never done before – reported an operating profit.
There are a lot of things to like about Fonterra's financial result this year.
Shoeshine, being a thrifty sort, loves a good rummage through the bargain bins.
Google the words “shareholder activism” and you will find just as many articles on how to defend it than how to execute it.
Shoeshine feels like a mushroom, a sensation she dislikes intensely. With special feature audio.
Roll up, roll up! Calling all young New Zealanders who can't get on the property ladder!
Trustpower's split into a largely New Zealand-based utility and a largely Australia-based windfarm developer is certain to cost shareholders up to $90 million.
NZX Limited has significantly underperformed the NZX S&P 50 Index over the past three years — and this has happened during one of the strongest equity market runs in history,